APO Research
Talk to an analyst

APO RESEARCH · REPORT

Third-Party Drug Testing Administration service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Third-Party Drug Testing Administration service Industry Growth and Trends Forecast to 2032

1 January 2026114 pages

Choose your research edition.

Industry ResearchThird-Party Drug Testing Administration service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Third-Party Drug Testing Administration service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Third-Party Drug Testing Administration service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Third-Party Drug Testing Administration service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Third-Party Drug Testing Administration service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Third-Party Drug Testing Administration service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Third-Party Drug Testing Administration service market include Lobdock, Info Cubic, Procom Testing, Midway, National Drug Screening, CO-OP Drug Testing, ADVANTAGECARE, CannAmm and Medway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Third-Party Drug Testing Administration service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Third-Party Drug Testing Administration service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Third-Party Drug Testing Administration service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Third-Party Drug Testing Administration service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Third-Party Drug Testing Administration service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Third-Party Drug Testing Administration service Market by Company

Lobdock

Info Cubic

Procom Testing

Midway

National Drug Screening

CO-OP Drug Testing

ADVANTAGECARE

CannAmm

Medway

AMDT

WorkPlace Health

Global Verification Network

Mobile Medical Corporation

DRUG TESTING CORPORATION

Origin

Third-Party Drug Testing Administration service Segment by Type

Pre-Employment Drug Testing

Reasonable Suspicion Drug Testing

Random Drug Testing

Return-to-Duty Drug Testing

Post-Accident Drug Testing

Others

Third-Party Drug Testing Administration service Segment by Application

SMEs

Large Enterprise

Third-Party Drug Testing Administration service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Third-Party Drug Testing Administration service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Third-Party Drug Testing Administration service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Third-Party Drug Testing Administration service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Third-Party Drug Testing Administration service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Third-Party Drug Testing Administration service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Third-Party Drug Testing Administration service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Third-Party Drug Testing Administration service Market Share by Region (2021-2026) Table 4. Global Third-Party Drug Testing Administration service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Third-Party Drug Testing Administration service Market Share by Region (2027-2032) Table 6. Global Third-Party Drug Testing Administration service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Third-Party Drug Testing Administration service Market Size Share by Type (2021-2026) Table 9. Global Third-Party Drug Testing Administration service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Third-Party Drug Testing Administration service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Third-Party Drug Testing Administration service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Third-Party Drug Testing Administration service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Third-Party Drug Testing Administration service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Third-Party Drug Testing Administration service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Third-Party Drug Testing Administration service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Third-Party Drug Testing Administration service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Third-Party Drug Testing Administration service Market Size Share by Application (2021-2026) Table 24. Global Third-Party Drug Testing Administration service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Third-Party Drug Testing Administration service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Third-Party Drug Testing Administration service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Third-Party Drug Testing Administration service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Third-Party Drug Testing Administration service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Third-Party Drug Testing Administration service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Third-Party Drug Testing Administration service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Third-Party Drug Testing Administration service Industry Trends Table 37. Third-Party Drug Testing Administration service Industry Drivers Table 38. Third-Party Drug Testing Administration service Industry Opportunities and Challenges Table 39. Third-Party Drug Testing Administration service Industry Restraints Table 40. Global Third-Party Drug Testing Administration service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Third-Party Drug Testing Administration service Revenue Market Share by Company (2021-2026) Table 42. Global Third-Party Drug Testing Administration service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Third-Party Drug Testing Administration service Key Company Headquarters & Area Served Table 44. Global Third-Party Drug Testing Administration service Company, Product Type & Application Table 45. Global Third-Party Drug Testing Administration service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Third-Party Drug Testing Administration service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lobdock Company Information Table 49. Lobdock Business Overview Table 50. Lobdock Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lobdock Third-Party Drug Testing Administration service Product Portfolio Table 52. Lobdock Recent Development Table 53. Info Cubic Company Information Table 54. Info Cubic Business Overview Table 55. Info Cubic Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Info Cubic Third-Party Drug Testing Administration service Product Portfolio Table 57. Info Cubic Recent Development Table 58. Procom Testing Company Information Table 59. Procom Testing Business Overview Table 60. Procom Testing Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Procom Testing Third-Party Drug Testing Administration service Product Portfolio Table 62. Procom Testing Recent Development Table 63. Midway Company Information Table 64. Midway Business Overview Table 65. Midway Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Midway Third-Party Drug Testing Administration service Product Portfolio Table 67. Midway Recent Development Table 68. National Drug Screening Company Information Table 69. National Drug Screening Business Overview Table 70. National Drug Screening Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. National Drug Screening Third-Party Drug Testing Administration service Product Portfolio Table 72. National Drug Screening Recent Development Table 73. CO-OP Drug Testing Company Information Table 74. CO-OP Drug Testing Business Overview Table 75. CO-OP Drug Testing Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. CO-OP Drug Testing Third-Party Drug Testing Administration service Product Portfolio Table 77. CO-OP Drug Testing Recent Development Table 78. ADVANTAGECARE Company Information Table 79. ADVANTAGECARE Business Overview Table 80. ADVANTAGECARE Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ADVANTAGECARE Third-Party Drug Testing Administration service Product Portfolio Table 82. ADVANTAGECARE Recent Development Table 83. CannAmm Company Information Table 84. CannAmm Business Overview Table 85. CannAmm Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. CannAmm Third-Party Drug Testing Administration service Product Portfolio Table 87. CannAmm Recent Development Table 88. Medway Company Information Table 89. Medway Business Overview Table 90. Medway Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Medway Third-Party Drug Testing Administration service Product Portfolio Table 92. Medway Recent Development Table 93. AMDT Company Information Table 94. AMDT Business Overview Table 95. AMDT Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AMDT Third-Party Drug Testing Administration service Product Portfolio Table 97. AMDT Recent Development Table 98. WorkPlace Health Company Information Table 99. WorkPlace Health Business Overview Table 100. WorkPlace Health Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. WorkPlace Health Third-Party Drug Testing Administration service Product Portfolio Table 102. WorkPlace Health Recent Development Table 103. Global Verification Network Company Information Table 104. Global Verification Network Business Overview Table 105. Global Verification Network Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Global Verification Network Third-Party Drug Testing Administration service Product Portfolio Table 107. Global Verification Network Recent Development Table 108. Mobile Medical Corporation Company Information Table 109. Mobile Medical Corporation Business Overview Table 110. Mobile Medical Corporation Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Mobile Medical Corporation Third-Party Drug Testing Administration service Product Portfolio Table 112. Mobile Medical Corporation Recent Development Table 113. DRUG TESTING CORPORATION Company Information Table 114. DRUG TESTING CORPORATION Business Overview Table 115. DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Product Portfolio Table 117. DRUG TESTING CORPORATION Recent Development Table 118. Origin Company Information Table 119. Origin Business Overview Table 120. Origin Third-Party Drug Testing Administration service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Origin Third-Party Drug Testing Administration service Product Portfolio Table 122. Origin Recent Development Table 123. North America Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Third-Party Drug Testing Administration service Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Third-Party Drug Testing Administration service Market Share by Country (2021-2026) Table 126. North America Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Third-Party Drug Testing Administration service Market Share Forecast by Country (2027-2032) Table 128. Europe Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Third-Party Drug Testing Administration service Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Third-Party Drug Testing Administration service Market Share by Country (2021-2026) Table 131. Europe Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Third-Party Drug Testing Administration service Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Third-Party Drug Testing Administration service Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Third-Party Drug Testing Administration service Market Share by Country (2021-2026) Table 136. Asia-Pacific Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Third-Party Drug Testing Administration service Market Share Forecast by Country (2027-2032) Table 138. Latin America Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Third-Party Drug Testing Administration service Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Third-Party Drug Testing Administration service Market Share by Country (2021-2026) Table 141. Latin America Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Third-Party Drug Testing Administration service Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Third-Party Drug Testing Administration service Market Share by Country (2021-2026) Table 146. Middle East & Africa Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Third-Party Drug Testing Administration service Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Third-Party Drug Testing Administration service Product Image Figure 3. Global Third-Party Drug Testing Administration service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 5. Global Third-Party Drug Testing Administration service Market Share by Region: 2025 VS 2032 Figure 6. Global Third-Party Drug Testing Administration service Market Share by Region (2021-2032) Figure 7. North America Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Pre-Employment Drug Testing Image Figure 13. Global Pre-Employment Drug Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Reasonable Suspicion Drug Testing Image Figure 15. Global Reasonable Suspicion Drug Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Random Drug Testing Image Figure 17. Global Random Drug Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Return-to-Duty Drug Testing Image Figure 19. Global Return-to-Duty Drug Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Post-Accident Drug Testing Image Figure 21. Global Post-Accident Drug Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Third-Party Drug Testing Administration service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Third-Party Drug Testing Administration service Market Share by Type 2025 VS 2032 Figure 26. North America Third-Party Drug Testing Administration service Market Size Share by Type (2021-2032) Figure 27. Europe Third-Party Drug Testing Administration service Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Third-Party Drug Testing Administration service Market Size Share by Type (2021-2032) Figure 29. Latin America Third-Party Drug Testing Administration service Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Third-Party Drug Testing Administration service Market Size Share by Type (2021-2032) Figure 31. SMEs Image Figure 32. Global SMEs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Large Enterprise Image Figure 34. Global Large Enterprise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Third-Party Drug Testing Administration service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Third-Party Drug Testing Administration service Market Share by Application 2025 VS 2032 Figure 37. North America Third-Party Drug Testing Administration service Market Size Share by Application (2021-2032) Figure 38. Europe Third-Party Drug Testing Administration service Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Third-Party Drug Testing Administration service Market Size Share by Application (2021-2032) Figure 40. Latin America Third-Party Drug Testing Administration service Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Third-Party Drug Testing Administration service Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Third-Party Drug Testing Administration service Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Third-Party Drug Testing Administration service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Third-Party Drug Testing Administration service Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 47. Europe Third-Party Drug Testing Administration service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Third-Party Drug Testing Administration service Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 50. Asia-Pacific Third-Party Drug Testing Administration service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Third-Party Drug Testing Administration service Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 53. Latin America Third-Party Drug Testing Administration service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Third-Party Drug Testing Administration service Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 56. Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Third-Party Drug Testing Administration service Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Pre-Employment Drug Testing
  • Reasonable Suspicion Drug Testing
  • Random Drug Testing
  • Return-to-Duty Drug Testing
  • Post-Accident Drug Testing
  • Others
Applications
  • SMEs
  • Large Enterprise
Companies covered
  • Lobdock
  • Info Cubic
  • Procom Testing
  • Midway
  • National Drug Screening
  • CO-OP Drug Testing
  • ADVANTAGECARE
  • CannAmm
  • Medway
  • AMDT
  • WorkPlace Health
  • Global Verification Network
  • Mobile Medical Corporation
  • DRUG TESTING CORPORATION
  • Origin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Third-Party Drug Testing Administration service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Third-Party Drug Testing Administration service Market Size by Region (2021-2032)
  5. 1.4.1 Global Third-Party Drug Testing Administration service Market Size by Region (2021-2026)
  6. 1.4.2 Global Third-Party Drug Testing Administration service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Third-Party Drug Testing Administration service Market Size (2021-2032)
  8. 1.5.1 North America Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Third-Party Drug Testing Administration service Market Size Growth Rate (2021-2032)
2 Third-Party Drug Testing Administration service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Pre-Employment Drug Testing
  3. 2.1.2 Reasonable Suspicion Drug Testing
  4. 2.1.3 Random Drug Testing
  5. 2.1.4 Return-to-Duty Drug Testing
  6. 2.1.5 Post-Accident Drug Testing
  7. 2.1.6 Others
  8. 2.2 Global Third-Party Drug Testing Administration service Market Size by Type
  9. 2.2.1 Global Third-Party Drug Testing Administration service Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Third-Party Drug Testing Administration service Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Third-Party Drug Testing Administration service Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Third-Party Drug Testing Administration service Market Size by Regions
  13. 2.3.1 North America Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Third-Party Drug Testing Administration service Market Size Breakdown by Type (2021-2026)
3 Third-Party Drug Testing Administration service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 SMEs
  3. 3.1.2 Large Enterprise
  4. 3.2 Global Third-Party Drug Testing Administration service Market Size by Application
  5. 3.2.1 Global Third-Party Drug Testing Administration service Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Third-Party Drug Testing Administration service Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Third-Party Drug Testing Administration service Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Third-Party Drug Testing Administration service Market Size by Regions
  9. 3.3.1 North America Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Third-Party Drug Testing Administration service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Third-Party Drug Testing Administration service Industry Trends
  2. 4.2 Third-Party Drug Testing Administration service Industry Drivers
  3. 4.3 Third-Party Drug Testing Administration service Industry Opportunities and Challenges
  4. 4.4 Third-Party Drug Testing Administration service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Third-Party Drug Testing Administration service Revenue (2021-2026)
  2. 5.2 Global Third-Party Drug Testing Administration service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Third-Party Drug Testing Administration service Key Company Headquarters & Area Served
  4. 5.4 Global Third-Party Drug Testing Administration service Company, Product Type & Application
  5. 5.5 Global Third-Party Drug Testing Administration service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Third-Party Drug Testing Administration service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Third-Party Drug Testing Administration service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Third-Party Drug Testing Administration service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lobdock
  2. 6.1.1 Lobdock Company Information
  3. 6.1.2 Lobdock Business Overview
  4. 6.1.3 Lobdock Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lobdock Third-Party Drug Testing Administration service Product Portfolio
  6. 6.1.5 Lobdock Recent Developments
  7. 6.2 Info Cubic
  8. 6.2.1 Info Cubic Company Information
  9. 6.2.2 Info Cubic Business Overview
  10. 6.2.3 Info Cubic Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Info Cubic Third-Party Drug Testing Administration service Product Portfolio
  12. 6.2.5 Info Cubic Recent Developments
  13. 6.3 Procom Testing
  14. 6.3.1 Procom Testing Company Information
  15. 6.3.2 Procom Testing Business Overview
  16. 6.3.3 Procom Testing Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Procom Testing Third-Party Drug Testing Administration service Product Portfolio
  18. 6.3.5 Procom Testing Recent Developments
  19. 6.4 Midway
  20. 6.4.1 Midway Company Information
  21. 6.4.2 Midway Business Overview
  22. 6.4.3 Midway Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Midway Third-Party Drug Testing Administration service Product Portfolio
  24. 6.4.5 Midway Recent Developments
  25. 6.5 National Drug Screening
  26. 6.5.1 National Drug Screening Company Information
  27. 6.5.2 National Drug Screening Business Overview
  28. 6.5.3 National Drug Screening Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 National Drug Screening Third-Party Drug Testing Administration service Product Portfolio
  30. 6.5.5 National Drug Screening Recent Developments
  31. 6.6 CO-OP Drug Testing
  32. 6.6.1 CO-OP Drug Testing Company Information
  33. 6.6.2 CO-OP Drug Testing Business Overview
  34. 6.6.3 CO-OP Drug Testing Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 CO-OP Drug Testing Third-Party Drug Testing Administration service Product Portfolio
  36. 6.6.5 CO-OP Drug Testing Recent Developments
  37. 6.7 ADVANTAGECARE
  38. 6.7.1 ADVANTAGECARE Company Information
  39. 6.7.2 ADVANTAGECARE Business Overview
  40. 6.7.3 ADVANTAGECARE Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ADVANTAGECARE Third-Party Drug Testing Administration service Product Portfolio
  42. 6.7.5 ADVANTAGECARE Recent Developments
  43. 6.8 CannAmm
  44. 6.8.1 CannAmm Company Information
  45. 6.8.2 CannAmm Business Overview
  46. 6.8.3 CannAmm Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 CannAmm Third-Party Drug Testing Administration service Product Portfolio
  48. 6.8.5 CannAmm Recent Developments
  49. 6.9 Medway
  50. 6.9.1 Medway Company Information
  51. 6.9.2 Medway Business Overview
  52. 6.9.3 Medway Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Medway Third-Party Drug Testing Administration service Product Portfolio
  54. 6.9.5 Medway Recent Developments
  55. 6.10 AMDT
  56. 6.10.1 AMDT Company Information
  57. 6.10.2 AMDT Business Overview
  58. 6.10.3 AMDT Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AMDT Third-Party Drug Testing Administration service Product Portfolio
  60. 6.10.5 AMDT Recent Developments
  61. 6.11 WorkPlace Health
  62. 6.11.1 WorkPlace Health Company Information
  63. 6.11.2 WorkPlace Health Business Overview
  64. 6.11.3 WorkPlace Health Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 WorkPlace Health Third-Party Drug Testing Administration service Product Portfolio
  66. 6.11.5 WorkPlace Health Recent Developments
  67. 6.12 Global Verification Network
  68. 6.12.1 Global Verification Network Company Information
  69. 6.12.2 Global Verification Network Business Overview
  70. 6.12.3 Global Verification Network Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Global Verification Network Third-Party Drug Testing Administration service Product Portfolio
  72. 6.12.5 Global Verification Network Recent Developments
  73. 6.13 Mobile Medical Corporation
  74. 6.13.1 Mobile Medical Corporation Company Information
  75. 6.13.2 Mobile Medical Corporation Business Overview
  76. 6.13.3 Mobile Medical Corporation Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Mobile Medical Corporation Third-Party Drug Testing Administration service Product Portfolio
  78. 6.13.5 Mobile Medical Corporation Recent Developments
  79. 6.14 DRUG TESTING CORPORATION
  80. 6.14.1 DRUG TESTING CORPORATION Company Information
  81. 6.14.2 DRUG TESTING CORPORATION Business Overview
  82. 6.14.3 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Product Portfolio
  84. 6.14.5 DRUG TESTING CORPORATION Recent Developments
  85. 6.15 Origin
  86. 6.15.1 Origin Company Information
  87. 6.15.2 Origin Business Overview
  88. 6.15.3 Origin Third-Party Drug Testing Administration service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Origin Third-Party Drug Testing Administration service Product Portfolio
  90. 6.15.5 Origin Recent Developments
7 North America
  1. 7.1 North America Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  3. 7.3 North America Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  3. 8.3 Europe Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  3. 10.3 South America Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Third-Party Drug Testing Administration service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst